Glivec (imatinib mesylate) in the treatment of polycythemia vera
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2014
At a glance
- Drugs Imatinib (Primary)
- Indications Polycythaemia vera
- Focus Therapeutic Use
- 18 Jun 2012 Actual patient number is 9 according to ClinicalTrials.gov.
- 18 Jun 2012 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.